AAPG V - Ascentage Pharma Group International

23.14
0.830   3.587%

Share volume: 374
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.14%

PREVIOUS CLOSE
CHG
CHG%
$22.31
0.83
0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
4.00%
1 Month
-1.99%
3 Months
-23.02%
6 Months
-42.72%
1 Year
24.41%
2 Year
34.14%
Key data
Stock price
$23.14
P/E Ratio 
N/A
DAY RANGE
$23.14 - $23.14
EPS 
N/A
52 WEEK RANGE
$17.56 - $48.45
52 WEEK CHANGE
$24.41
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$2,800
AVERAGE 30 VOLUME 
$2,129
Company detail
CEO: Dajun Yang
Region: US
Website: www.ascentage.com
Employees: 600
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

We are a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies. Our headquarters and principal executive office is located in Suzhou, Jiangsu, China.

Recent news